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Utility and safety of a new uneven 
double-lumen sphincterotome in cases 
of difficult biliary cannulation
Shuhei Shintani1, Osamu Inatomi1* , Yoshiya Takeda1, Hiroshi Matsumoto1, Takehide Fujimoto1, 
Yoshihisa Tsuji2, Hiromu Kutsumi3 and Akira Andoh1
Abstract 
Background: We investigated the utility and safety of a new uneven double-lumen sphincterotome in biliary can-
nulation in comparison with the conventional pancreatic guidewire (PGW) method.
Methods: We retrospectively evaluated 119 patients who required PGW placement because of difficult biliary cannu-
lation. Endoscopic retrograde cholangiopancreatography (ERCP) was performed using a conventional ERCP catheter 
or a new uneven double-lumen sphincterotome. The success rate of bile duct cannulation, the operation time of bile 
duct cannulation, and the incidence of post-ERCP pancreatitis (PEP) were evaluated.
Results: Forty-four patients were treated with a new double-lumen sphincterotome (the new sphincterotome 
group) and 75 patients underwent conventional PGW placement (the conventional group). The success rate of bile 
duct cannulation was 39/44 (88.6%) in the new sphincterotome group and 63/75 (84.0%) in the conventional group 
(not significant). The total biliary cannulation time (from the reach to the papilla to the finish of biliary cannulation) 
was 16.0 (6.5–78) min in the new sphincterotome group and 26.0 (5–80) min in the conventional group (P < 0.01). The 
time from PGW placement to bile duct cannulation was 3.5 (0.3–57) min in the magictome group and 12.0 (1–65) min 
in the conventional group (P < 0.01). Hyperamylasemia was observed in 13/44 (29.5%) and 17/75 (22.7%), respectively 
(not significant). Five of 44 (11.3%) of the new sphincterotome group and 14/75 (18.7%) of the conventional group 
were diagnosed with PEP (not significant).
Conclusion: A new double-lumen sphincterotome allows selective bile duct cannulation to be performed in a 
shorter time than the conventional PGW method.
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Background
Endoscopic retrograde cholangiopancreatography 
(ERCP) is a standard technique for diagnosis and treat-
ment of biliary disorders [1]. Various devices and tech-
niques have been developed to improve the success rate 
of cannulation [1–3], but in some cases selective bile duct 
cannulation remains difficult due to papillary spasm and/
or anatomical problem. Difficulty or failure of selective 
bile duct cannulation leads to a lengthening of procedure 
time and sometimes causes post-ERCP pancreatitis (PEP) 
that is occasionally fatal [4–6].
Pancreatic guidewire (PGW) placement has been 
reported to facilitate selective bile duct cannulation [1, 7]. 
PGW placement stabilizes the mobility of the papilla and 
linearize the distal part of the bile duct [3], leading to an 
increased success rate for selective bile duct cannulation. 
On the other hand, PGW placement has been reported 
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to be associated with a risk of PEP due to contrast media 
injection and/or mechanical injury of the pancreatic duct 
[8]. PGW placement includes several steps: cannula-
tion into the pancreatic duct to insert a guidewire, pull 
off the pancreatic cannula while retaining the guidewire, 
and cannulation or guidewire insertion into the bile duct 
[9]. These processes are somewhat complicated and time 
consuming. Moreover, placed PGW sometimes disturbs 
next approach to the common bile duct.
MagicTome® (Piolax Inc., Yokohama, Japan) is a new 
double-lumen sphincterotome with distal (tip) and 
proximal (side) holes (Fig.  1). Each lumen is 0.025 inch 
in diameter. The distance between the distal and proxi-
mal holes is 17 mm. This device allows PGW placement 
and bile duct cannulation without the need to change 
any devices. This may shorten total procedure time and 
improve the success rate of selective biliary cannulation. 
In 2018, we changed the cannulation method from con-
ventional PGW placement using a single-lumen catheter 
to MagicTome®. In this study, we investigated whether 
MagicTome® reduces the operation time and alters the 
incidence of PEP after PGW placement.
Methods
Patients
From January 2013 to February 2020, 1,311 patients 
underwent ERCP at the Shiga University of Medical 
Science Hospital. Of these, we retrospectively evaluated 
119 patients who required PGW placement because of 
difficult bile duct cannulation (a conventional cannu-
lation into the bile duct needing more than 10 min or 
10 unsuccessful attempts). ERCP was performed using 
a conventional ERCP catheter (MTW ERCP catheter: 
ABIS, Tokyo, Japan) from January 2013 to May 2018 
(the conventional group) and the MagicTome® sphinc-
terotome (Piolax) from June 2018 to February 2020 (the 
magictome group). Patients with a history of endo-
scopic sphincterotomy (EST), Billroth II surgery or 
pancreatic disease were excluded. All data related to 
ERCP was stored as a video and electronic database. 
All patients provided a written informed consent prior 
to undergoing ERCP. This study was approved by the 
ethics committee of the Shiga University of Medical 
Science (No. R2019-115). A trainee was defined as an 
operator who had performed fewer than 100 ERCP pro-
cedures within 5 years.
Endoscopic procedure
A combination of midazolam and pentazocine were 
used for conscious sedation in all patients until 2014, 
and dexmethomidine was added from 2015. ERCP was 
conducted with a side-viewing duodenoscope JF260V 
(Olympus Optical Co., Tokyo, Japan) and an ERCP 
guidewire Visiglide2® (Olympus). A pancreatic duct 
stent (Geenen® 5Fr, Cook Medical, Tokyo, Japan) was 
applied if the operator required it in cases where EST 
was not performed. When performing the PGW place-
ment, pancreatography was performed using a mini-
mal amount of contrast injection. After confirming the 
clearance of contrast media from the pancreatic duct, a 
guidewire was inserted into the deep pancreatic duct. 
Fig. 1 a MagicTome® (Piolax Inc., Yokohama, Japan) is a new double-lumen sphincterotome with distal (tip) and proximal (side) holes. b The angle 
of the device tip can be adjusted by raising the head
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When PGW placement did not successfully achieve bil-
iary cannulation, a precut sphincterotomy or another 
maneuver was performed.
Selective bile duct cannulation using a double‑lumen 
sphincterotome
MagicTome® (Piolax) is a sphincterotomy knife with a 
double lumen at the tip and side holes. The pancreatic 
duct is fixed by the guidewire from the proximal (side) 
hole, and the bile duct and pancreatic duct are separated 
by raising the catheter tip. This enables subsequent bile 
duct cannulation from the distal (tip) hole. A schema 
of the typical process is presented in Fig.  2. (a) The 
operator inserts the guidewire into the pancreatic duct 
from the distal (tip) hole. (b) Then, the operator should 
slightly place the catheter into the pancreatic duct and 
insert another guidewire in the pancreatic duct from 
the proximal (side) hole. (c) The operator pulls the tip of 
the guidewire into the catheter, and then pulls the cath-
eter back to the duodenum while retaining the pancreas 
guidewire. (d) The approach to the papilla and bile duct 
can be performed from the duodenum. This method does 
not require the exchange or removal of any devices dur-
ing the procedure.
Outcome
We investigated the success rate of bile duct cannulation, 
the operation time and the incidence of PEP of the biliary 
cannulation using MagicTome® in comparison with the 
conventional method using a single-lumen catheter.
Safety evaluation
Hyperamylasemia, PEP, bleeding, perforation, and chol-
angitis were evaluated as complications. Diagnosis and 
disease severity of PEP were based on the criteria of Cot-
ton et al. [4]. These include newly developed abdominal 
pain and elevation of serum amylase levels 3 times over 
the upper limit of normal level within 24 h [4].
Statistical analysis
The continuous variables pertaining to the baseline char-
acteristics of the two groups were compared by using the 
Student’s t-test or the Wilcoxon rank-sum test, as appro-
priate. Categorical variables were compared using the 
chi-square or Fisher’s exact test. Values of p < 0.05 were 
considered to be significantly different. Multivariate anal-
ysis was performed on factors that had p < 0.10 in the uni-
variate analysis. All statistical analyses were performed 
using EZR version 1.40 (Jichi Medical University, Shimo-
tsuke, Japan).
Results
There were no significant differences in patients’ charac-
teristics between the magictome group and the conven-
tional group (Table 1).
Of 119 patients who underwent PGW placement, 44 
patients were treated with MagicTome® (the magictome 
group) and 75 patients underwent conventional PGW 
placement (the conventional group) (Fig. 3). The success 
rate of bile duct cannulation was 39/44 (88.6%) in the 
magictome group and 63/75 (84.0%) in the conventional 
group (no significant difference) (Table 2). Of 5 patients 
with bile duct cannulation failure in the magictome 
group, 3 patients subsequently received precut sphinc-
terotomy, but bile duct cannulation was a failure in 2 
patients. In the conventional group, bile duct cannulation 
was unsuccessful in 12 patients, and 7 patients were suc-
cessfully cannulated after precut sphincterotomy (Fig. 3).
The total biliary cannulation time (from the reach to 
the papilla to the finish of bile duct cannulation) was 16.0 
(6.5–78) min in the magictome group and 26.0 (5–80) 
min in the conventional group (P < 0.01) (Table  2). The 
time from PGW placement to biliary cannulation was 
3.5 (0.3–57) min in the magictome group and 12.0 (1–65) 
min in the conventional group (P < 0.01).
Placement of a pancreatic duct stent was performed in 
10/44 (22.7%) in the magictome group and 18/75 (24.0%) 
in the conventional group (no significant difference). 
Hyperamylasemia was observed in 13/44 (29.5%) of the 
magictome group and 17/75 (22.7%) in the conventional 
group (no significant difference) (Table  2). Five of 44 
(11.3%) of the magictome group and 14/75 (18.7%) of the 
conventional group were diagnosed with PEP (no signifi-
cant difference) (Table 2).
Discussion
This study revealed a number of important points regard-
ing the use of MagicTome® in selective bile duct cannula-
tion. While MagicTome® significantly shortened the bile 
duct cannulation time, it did not alter the success rate of 
the procedure. Complication rates associated with Mag-
icTome® use were comparable to those of the conven-
tional PGW placement.
PGW placement, such as the contrast-medium 
method and the contrast-free guidewire cannulation 
method, has been reported to be useful for selective 
biliary cannulation in patients in whom biliary can-
nulation is difficult [10]. The PGW method was first 
reported in 1998 by Dumonceau et  al. as useful for 
biliary cannulation in Billroth I gastrectomy cases 
[11]. Gotoh et  al. reported the usefulness of the dou-
ble-guidewire method to straighten a tortuous pan-
creatic duct [12]. Ito et al. reported that 82 out of 113 
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(72.6%) patients with difficulties in biliary cannulation 
were successfully cannulated by PGW placement [10]. 
However, PGW placement requires the removal of the 
pancreas catheter while retaining the guidewire left in 
the pancreatic duct. This step is inconvenient and time-
consuming. The placed PGW occasionally disturbs 
next approach to the common bile duct. Moreover, it is 





Fig. 2 Process of selective bile duct cannulation using MagicTome®. a The guidewire is initially inserted into the pancreatic duct through the 
distal (tip) hole. b The catheter should be slightly put into the pancreatic duct, and another guidewire inserted into the pancreatic duct from the 
proximal (side) hole. c The guidewire inserted from the distal (tip) hole should be pulled into the catheter, and the catheter itself pulled back to the 
duodenum. d The approach to the papilla and bile duct can be performed from the duodenum. This method is characterized by not requiring the 
exchange or removal of any devices during the procedure. e Fluoroscopic image showing two guidewires in the pancreatic duct. f Fluoroscopic 
image showing successful bile duct cannulation
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in the direction of the bile duct, which delays biliary 
cannulation.
In a novel approach, Takenaka et al. recently reported 
the usefulness of a newly-developed biliary cannulation 
method for difficult cannulation cases using a unique, 
uneven, double-lumen cannula (uneven method) [2, 13]. 
They reported that their cannula straightened the pan-
creatic duct and the common channel, thereby effectively 
stabilizing the papilla and enabling easy adjustment of 
the catheter axis to comply with the bile duct direction.
In this study, we reported a new bile duct cannulation 
method for difficult cannulation cases using a Magic-
Tome® sphincterotome. Similar to the uneven cannula 
used by Takenaka et al., MagicTome® is a uneven double-
lumen sphincterotome with distal and proximal holes. 
However, there are several differences in the method of 
bile duct cannulation between the uneven cannula and 
MagicTome®. PGW placement using the uneven can-
nula is initiated via the distal (tip) hole, whereas using the 
MagicTome® it is placed via the proximal (lateral) hole. 
The tip of the uneven cannula is inserted and fixed in the 
pancreatic duct, but MagicTome® can move freely and 
allows free approach to the papilla or common bile duct. 
When needed, precut sphincterotomy is easily performed 
with MagicTome® without any device exchange. Thus, 
there are a number of differences in bile duct cannulation 
approach between the uneven cannula and MagicTome®.
The success rate of bile duct cannulation tended to be 
higher in the magictome group (88.6%) than in the con-
ventional group (84%), but there was no significant dif-
ference. The current study was performed in cases of 
difficult biliary cannulation, and the successful cannu-
lation rate in this study is acceptable when comparing 
with previous reports [9, 14]. This issue should be pro-
spectively reconfirmed in a multicenter study with much 
greater number of patients. Both total biliary cannula-
tion time and the time from PGW placement to bile duct 
cannulation were significantly reduced in the magictome 
Table1 Patients characteristics
CBD, common bile duct; ASA, American Society of Anesthesia Classification (Owens WD, et al. Anesthesiology 1978, 49:239–243.); EST, endoscopic sphincterotomy; 
EPBD, endoscopic papillary balloon dilation; IDUS, intraductal ultrasound sonography; EBD, endoscopic biliary drainage
The magictome group The conventional group P value
n = 44 n = 75
Age, median (range), year 72.0 (42–89) 74.0 (36–93) 0.36
Sex (male/female), n 25 /19 48/27 0.56
Indication of ERCP, n (%)
 CBD stone 24 (54.5) 38 (50.7) 0.83
 Neoplasm 16 (36.4) 22 (29.3) 0.56
 Others 4 (9.1) 15 (20.0) 0.13
ASA ≥ 3, n (%) 4 (9.1) 9 (12.0) 0.77
Anticoagulant use, n (%) 7 (15.9) 17 (22.7) 0.52
Duodenum diverticulum, n (%) 3 (6.8) 5 (6.7) 1.0
Oral protrusion of the papilla, mm (mean ± SD) 10.4 ± 4.9 9.7 ± 2.9 0.33
Purpose of ERCP, n (%)
 EST 27 (61.4) 39 (52.0) 0.42
 EPBD 1 (2.3) 6 (8.0) 0.26
 IDUS 15 (34.1) 16 (21.3) 0.19
 EBD 20 (45.5) 31 (41.3) 0.81
 Biopsy 2 (4.5) 3 (4.0) 1.0
Cases performed by trainee, n (%) 22 (50.0) 32 (42.7) 0.56














Precut 3 Unsuccess 2 Precut 7 EUS-BD 1 Unsuccess 4
Fig. 3 Flowchart showing the treatment course of the 
patients enrolled in this study. ERCP: endoscopic retrograde 
cholangiopancreatography, PGW: pancreatic duct guidewire, precut: 
precut sphincterotomy, EUS-BD: endoscopic ultrasound biliary 
drainage
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group compared to the conventional group. These find-
ings indicate that MagicTome® use is effective in shorten-
ing the operation time for selective bile duct cannulation 
in patients where biliary cannulation is difficult. This 
may be associated with the fact that MagicTome® needs 
no device exchange. Previously reported effects of PGW 
placement such as opening a stenotic papillary orifice, 
stabilizing the papilla and straightening the pancreatic 
duct and the common channel might be also involved 
[14]. In addition, its ability to easily adjust its axis to com-
ply with the bile duct direction might contribute to the 
shortening of operation time. Shortening the operation 
time may benefit not only the risk of PEP but also com-
plication associated with sedation and radiation exposure 
of the operators.
Precut sphincterotomy seemed to be ineffective in the 
magictome group compared to the conventional group. 
Although the number of patients with unsuccessful bil-
iary cannulation in the magictome group was small 
(n = 3), such patients might have anatomical constraints 
that make cannulation particularly difficult.
Many studies reported prophylactic effect of pancreatic 
duct stent placement on PEP [15, 16]. However, the ben-
efit remains still controversial in terms of the costs and 
risks associated with approaching the pancreatic duct 
[17]. Therefore, in the present study, placement of pan-
creatic duct stent was performed in a limited number of 
patients. Information bias was minimal as the frequency 
was comparable between two groups.
The safety of MagicTome® use was confirmed to some 
extent, since there were no significant differences in the 
incidence of hyperamylasemia and PEP between the 
magictome group and the conventional group. Pancrea-
titis remains the most common complication of ERCP, 
occurring in 4% to 7% of unselected patients to 30% in 
high-risk patients [8, 18, 19]. The edema of the papilla 
caused by repeated cannulation and/or the increased 
pressure from contrast injection are risk factors for PEP 
[19]. The influence of PGW placement on PEP remains 
controversial. PGW placement has been reported to 
improve the success rate of bile duct cannulation, reduce 
papillary trauma, and avoid inadvertent contrast injec-
tion, thereby reducing the risk of PEP [19]. On the other 
hand, mechanical injury of the pancreatic duct by PGW 
has been reported to be a potential risk factor [19], sug-
gesting that the shortening of retaining time of PGW 
using MagicTome® may reduce the incidence of PEP.
Conclusions
The MagicTome® technique is a feasible and safe method 
in difficult bile duct cannulation avoiding the compli-
cated processes that occur in the conventional PGW 
method. This was a retrospective, single-center study 
comparing MagicTome® use with the conventional tech-
nique. As such, the usefulness and safety of MagicTome® 
including the issues other than those assessed in this 
study should be investigated in a prospective randomized 
study in the future.
Abbreviations
ERCP: Endoscopic retrograde cholangiopancreatography; PGW: Pancreatic 
guidewire; PEP: Post-ERCP pancreatitis; precut: Precut sphincterotomy; EUS-
BD: Endoscopic ultrasound biliary drainage; CBD: Common bile duct; ASA: 
American Society of Anesthesia Classification; EST: Endoscopic sphincterot-
omy; EPBD: Endoscopic papillary balloon dilation; IDUS: Intraductal ultrasound 





a From the reach to the papilla to the finish of biliary cannulation
The magictome group The conventional group P value
n = 44 n = 75
Successful biliary cannulation, n (%) 39 (88.6) 63 (84.0) 0.67
Procedure time, min, median (range)
 Total biliary cannulation  timea 16.0 (6.5–78) 26.0 (5–80) < 0.01
 Time from PGW placement to biliary cannulation 3.5 (0.3–57) 12.0 (1–65) < 0.01
Complications, n (%)
 Hyperamylasemia 13 (29.5) 17 (22.7) 0.54
 PEP 5 (11.4) 14 (18.7) 0.44
 Cholangitis 3 (6.8) 2 (2.7) 0.36
 Bleeding 1 (2.3) 4 (5.3) 0.65
 Perforation 0 1 (1.3) 1.0
Placement of pancreatic duct stent, n (%) 10 (22.7) 18 (24.0) 1.0
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